Appreciation, gratitude, and looking forward.

As CJASN continues to advance and innovate, it is gratifying to see the tremendous growth in the number of high-quality manuscripts submitted for consideration. As a result, the selection of manuscripts for publication has become a privilege and a challenge (our acceptance rate is now 15%). The success of the journal is directly related to the hard work and devotion of the individuals who make up the CJASN team.We are very fortunate to have two extraordinary Deputy Editors who provide wise counsel and serve as role models for the nephrology community. A long overdue welcome goes to Dr. Kirsten Johansen, a widely recognized and distinguished scientist and clinician, who has been an invaluable addition and brings substantial journal editor experience to our team. Her attention to detail and commitment to quality continue to raise the bar for the articleswe publish. Dr. Paul Palevsky, an internationally recognized nephrologist and investigator, cultivates the highestquality invited material with his scientific acumen and discerning oversight. Paul’s determination and devotion to the new Renal Physiology Series, being launched in the July issue, exemplifies his commitment to education, scientific rigor, and clinical excellence. We are deeply grateful to Dr. Barbara Murphy, Dr. Braden Manns, and Dr. David Goldsmith for their invaluable dedication and 3 years of service as Associate Editors for CJASN. The contributions of each of these talented individuals are immeasurable. We are thrilled towelcome three very accomplished clinicians and scientists as new Associate Editors. Dr. Roslyn Mannon is a highly respected transplant nephrologist and recent past-president of the American Society of Transplantation. Dr. Ann O’Hare is admired for her extensive research on older adults and end-of-life care in renal patients. Dr. Vlado Perkovic, Executive Director of the esteemed George Institute for Global Health in Sydney, Australia, brings his highly regarded expertise in clinical trials and meta-analysis and shares an international perspective. These three new Associate Editors join the exceptional group of individuals who have served as outstanding Associate Editors for the past 3 years and will continue to serve another 3-year term: Drs. Michael Allon, Lakhmir (Mink) Chawla, Jeffrey Fink, Linda Fried, Susan Furth, David Goldfarb, Mark Perazella, and Katherine Tuttle. These individuals, who are all practicing nephrologists, serve the most important role in the review of original manuscripts. The quality of our published manuscripts is a testament to their knowledge, experience, and passion for science and clinical care. The manuscript evaluation process fundamentally relies on, andbenefits from, the expertise of thehundreds of reviewers who provide their constructive feedback to the authors and editors, and we are grateful for their considerable time and effort. We are particularly indebted to our outstanding Editorial Board, whose guidance ensures a consistent level of excellence. I would like togiveaveryspecial thankyoutoourdedicatedEditorial Boardmemberswho have completed their 3-year terms; their wisdom and insight have been invaluable assets. Please join me in welcoming our new members to the Editorial Board, whose names are listed in the front of each issue. We truly benefit from the talents of so many superb professionals. The journal has benefitted greatly from the skillful managementofCJASNManagingEditor, ShariLeventhal, whose focus on continuous quality improvement, timeliness, and “author support” has tremendously enhanced all aspects of the journal. We are very appreciative of the willingness of the CJASNEditors andEditorial Board to adhere toCJASN’s standards for reporting conflicts of interest. Given the significance of reporting potential conflicts of interest, the CJASN Editors and Editorial Board are asked to update their disclosures on an annual basis, and the full disclosures are posted on the CJASN website. Completion of disclosures is required for participation on the CJASN Editorial Team and Editorial Board. The 2014 disclosures are available on the CJASN website. As Editor-in-Chief, I find it gratifying to see the great strides the journal has made toward the paramount goal of publishing material that meets the highest standards for quality and clarity. As we reflect on the journal’s past accomplishments and progress, the collective enthusiasm, energy, and creativity of our contributors, editors, and readership inspire our ongoing attention to continued improvement, growth, and expansion while we strive for excellence. It is with great excitement that we launch several new series. Renal Physiology for the Clinician, edited by the experienced educators Dr. Melanie Hoenig and Dr. Mark Zeidel, will begin in print in July and will ultimately include 18 articles. This series will review key aspects of renal physiology, highlight recent advances inour understanding, and present clinically relevant examples. Our goal for this series is to create a readily accessible review of material that will serve as a valuable resource Channing Division of Network Medicine, Renal Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts